Copia Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1K Hold
160
0.02% 269
2026
Q1
$24.4K Hold
160
0.02% 262
2025
Q4
$22.1K Hold
160
0.02% 262
2025
Q3
$20.5K Hold
160
0.02% 262
2025
Q2
$19.4K Hold
160
0.02% 242
2025
Q1
$17.8K Sell
160
-40
-20% -$4.26K 0.02% 235
2024
Q4
$19.5K Buy
+200
New +$21.3K 0.02% 214

Other funds holding NVS

Copia Wealth Management's NVS Position: Q2 2026 in Review

Copia Wealth Management held its Novartis (NVS) position steady in Q2 2026 at 160 shares worth $25.1K. The position accounts for 0.02% of the portfolio, ranked #269.

Copia Wealth Management first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Copia Wealth Management held 160 shares of Novartis worth $25.1K as of Q2 2026.
  • Copia Wealth Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.02% of Copia Wealth Management's portfolio in Q2 2026, its #269 holding.
  • Copia Wealth Management first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Copia Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.